Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28085563)
Watch
English
Engineering New Approaches to Cancer Vaccines
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
1 reference
stated in
Europe PubMed Central
title
Engineering New Approaches to Cancer Vaccines
(English)
1 reference
stated in
PubMed
author
Kelly D Moynihan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
author name string
Naveen K Mehta
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
Darrell J Irvine
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
language of work or name
English
1 reference
stated in
PubMed
publication date
August 2015
1 reference
stated in
PubMed
published in
Cancer Immunology Research
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
volume
3
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
issue
8
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
page(s)
836-843
1 reference
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
cites work
Trial watch: IDO inhibitors in cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
20 March 2017
Cancer immunotherapy: moving beyond current vaccines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
20 March 2017
The future of immune checkpoint therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
20 March 2017
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
20 March 2017
Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
20 March 2017
T-Cell Function and Migration — Two Sides of the Same Coin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
7 April 2017
Tissue engineering
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
7 April 2017
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
A single dose biodegradable vaccine depot that induces persistently high levels of antibody over a year.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Classical Flt3L-dependent dendritic cells control immunity to protein vaccine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Therapeutic vaccines for cancer: an overview of clinical trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Subcutaneous drug delivery and the role of the lymphatics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Structure-based programming of lymph-node targeting in molecular vaccines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Dendritic-cell-based therapeutic cancer vaccines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Combining immunotherapy and targeted therapies in cancer treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Programming the magnitude and persistence of antibody responses with innate immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Nanoparticle delivery systems in cancer vaccines.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
In situ regulation of DC subsets and T cells mediates tumor regression in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Infection-mimicking materials to program dendritic cells in situ
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Intralymphatic immunization enhances DNA vaccination.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
29 September 2017
Rational design of small molecules as vaccine adjuvants.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
2 June 2018
Personal neoantigen cancer vaccines: The momentum builds
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
2 June 2018
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
2 June 2018
Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
2 June 2018
Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Nanoparticles target distinct dendritic cell populations according to their size
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Direct intralymphatic injection of peptide vaccines enhances immunogenicity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4527881
retrieved
27 November 2018
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26156157
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26156157
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26156157
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
BCG immunotherapy of malignant melanoma: summary of a seven-year experience
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26156157
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Vaccine adjuvant activity of 3M-052: an imidazoquinoline designed for local activity without systemic cytokine induction
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26156157
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26156157
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1158/2326-6066.CIR-15-0112
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
PMC publication ID
4527881
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
PubMed publication ID
26156157
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4527881
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26156157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 June 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
